SSKN Overview

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

Wall Street analysts forecast SSKN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SSKN is4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Strata Skin Sciences Inc revenue for the last quarter amounts to 6.93M USD, decreased -21.23

Strata Skin Sciences Inc. EPS for the last quarter amounts to -0.36 USD, decreased -29.41

Strata Skin Sciences Inc (SSKN) has 106 emplpoyees as of March 25 2026.

Today SSKN has the market capitalization of 10.90M USD.